Biotin Price Chart, Graph and Demand

Biotin Price In USA

• United States: 278,595 USD/MT

In the fourth quarter of 2023, the price of Biotin in the United States reached 278,595 USD/MT by December.

The latest report by IMARC Group, titled "Biotin Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data," provides a thorough examination of Biotin Prices. This report delves into the price of Biotin Globally, presenting a detailed analysis, along with an informative Biotin Price Chart. Through comprehensive price analysis, the report sheds light on the key factors influencing these trends. Additionally, it includes historical data to offer context and depth to the current pricing landscape. The report also explores the demand, analyzing how it impacts market dynamics. To aid in strategic planning, the price forecast section provides insights into price forecast, making this report an invaluable resource for industry stakeholders.

Biotin Price Analysis:

• China: 150,000 USD/MT
• Germany: 168,495 USD/MT

Report Offering:

• Monthly Updates: Annual Subscription
• Quarterly Updates: Annual Subscription
• Biannually Updates: Annual Subscription

The study delves into the factors affecting Biotin price variations, including alterations in the cost of raw materials, the balance of supply and demand, geopolitical influences, and sector-specific developments.

The report also incorporates the most recent updates from the market, equipping stakeholders with the latest information on market fluctuations, regulatory modifications, and technological progress. It serves as an exhaustive resource for stakeholders, enhancing strategic planning and forecast capabilities.

Request For a Sample Copy of the Report:  https://www.imarcgroup.com/biotin-pricing-report/requestsample

Biotin Prices- Last Quarter

The biotin market is experiencing growth due to increasing consumer awareness about its benefits for hair, skin, and nail health. As more people seek dietary supplements to enhance their beauty routines, there has been a rise in demand for biotin, a key ingredient in many multivitamins and standalone supplements. Additionally, the growing focus on wellness and preventive healthcare is driving consumers to incorporate biotin into their daily regimen for its perceived health benefits. There is also a noticeable trend toward natural and plant-based biotin sources, as consumers prefer clean-label products. Moreover, the expansion of e-commerce and online retailing is making biotin supplements more accessible, further supporting market growth. These trends indicate a positive outlook for the biotin market in the coming years.

Biotin Industry Analysis

Prices for biotin have been steadily declining in the North American market since the second quarter of 2024, mostly due to a combination of persistent economic difficulties. Deteriorating demand from end-user sectors, high inventory levels, and supply chain disruptions have all contributed significantly to the downward pressure on market pricing. Additionally, the ongoing inflationary environment has made consumers more frugal with their expenditures, which has made the declining demand even worse. A -5% decrease from Q1 2024 is seen in the quarter-over-quarter study, highlighting the continued low demand and plentiful supply.

Moreover, the APAC biotin market has experienced a difficult second half of 2024 due to a steady drop in prices. The market’s excess supply increased financial strains, and weak demand from downstream industries are the main causes of the declining trend. These concerns were further aggravated by the ongoing economic recession that was made worse by trade barriers and geopolitical tensions. Notably, to effectively manage supply chains in the face of unstable market conditions, market participants were seen selling their stockpiles at reduced prices. China, the center of major price fluctuations, witnessed a sharp reduction of -29% from the same quarter the previous year and -5% from 2024's prior quarter. 

Furthermore, the European biotin market witnessed a steady price reduction in Q2 2024, which was indicative of a generally unfavorable pricing climate. Several important elements that contributed to the declining trend were seen this quarter. A major factor in the price drop was the downstream sectors' muted demand and cautious consumer spending due to fears about inflation. The sharp decline in market circumstances was highlighted by the sharp 27% drop in pricing from Q2 2023 when comparing year-over-year data.

Browse Full Report:-  https://www.imarcgroup.com/biotin-pricing-report

Regional Price Analysis:

• Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand.
• Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal and Greece.
• North America: United States and Canada.
• Latin America: Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru
• Middle East & Africa: Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco.

Note: The current country list is selective, detailed insights into additional countries can be obtained for clients upon request.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145